A open-label, comparative, multicenter, randomised, phase IV study to assess the efficacy of Seroquel and Chlorpromazine for the treatment Schizophrenia in Chinese patients for 8 weeks, Seroquel PhaseIV

Study identifier:5077CN001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A open-label, comparative, multicenter, randomised, phase IV study to assess the efficacy of Seroquel and Chlorpromazine for the treatment Schizophrenia in Chinese patients for 8 weeks, Seroquel PhaseIV

Medical condition

schizophrenia

Phase

Phase 4

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Oct 2002
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

-

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria